SUBSCRIBE
SUBSCRIBE

True North Therapeutics, Inc.

NEWS
Drug Development
Star Therapeutics Starts a Family with Electra
Star Therapeutics has exited stealth mode and announced a spin-off company, Electra Therapeutics.
February 16, 2022
 · 
3 min read
 · 
Hayley Shasteen
Business
VC Startup Westlake Village BioPartners Launches With Amgen Vets, $320 Million Fund
There is a new player in the southern California biotech industry. New venture firm Westlake Village BioPartners launched with a $320 million fund and a leadership well familiar with the ins and outs of the biotech and pharma world.
September 5, 2018
 · 
2 min read
 · 
Alex Keown
3 Biotechs That Could be Taken Out This Quarter
Business
Biogen Spinoff Bioverativ Takes Out Bay Area’s True North in $825 Million Deal
May 23, 2017
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Biotech Bay
Tiny Bay Area Biotech True North Therapeutics Bags $45 Million, Bringing the Total to $142 Million
October 18, 2016
 · 
3 min read
Business
Top 20 Life Science Startups to Watch in the U.S.
BioSpace is pleased to present its NextGen Bio “Class of 2016.” This list contains 20 life science companies that launched no earlier than 2013 and are headquartered in the United States.
January 26, 2016
 · 
15 min read
 · 
Mark Terry
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Business
With Almost $100 Million in Financing, Bay Area’s True North Therapeutics Jumps Into Immune System Clinical Trials
December 3, 2015
 · 
3 min read
What You Need to Know About True North Therapeutics
Business
What You Need to Know About True North Therapeutics
December 2, 2015
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
True North Therapeutics CEO Delivers With $35 Million to Take Lead Candidate Into Clinical Trial
April 7, 2015
 · 
2 min read
AWARDS
  • NextGen Class of 2016
IN THE PRESS
Deals
Bioverativ Completes Acquisition Of True North
June 29, 2017
 · 
5 min read
Business
True North Therapeutics Appoints Biotechnology Commercial Executive Jeff Ajer To Its Board Of Directors
February 1, 2017
 · 
2 min read
Biotech Bay
True North Therapeutics Presents Additional Data From An Ongoing Clinical Study Showing Normalization Of Hemoglobin Levels With TNT009 In Severely Anemic Cold Agglutinin Disease (CAD) Patients
December 5, 2016
 · 
4 min read
Drug Development
True North Therapeutics Receives FDA Orphan Drug Designation For TNT009 For The Treatment Of Autoimmune Hemolytic Anemia, Including Cold Agglutinin Disease (CAD)
October 13, 2016
 · 
3 min read
Business
True North Therapeutics Appoints Pamela M. Wapnick As Chief Financial Officer
August 2, 2016
 · 
2 min read
Drug Development
True North Therapeutics To Present Clinical Data In Patients With Cold Agglutinin Disease (CAD) For Lead Product Candidate TNT009
June 13, 2016
 · 
3 min read
Drug Development
True North Therapeutics ’s Lead Product Candidate, TNT009, Demonstrates High Response Rates And Rapid Onset Of Action In Interim Clinical Data In Patients With Cold Agglutinin Disease (CAD)
June 13, 2016
 · 
4 min read
Drug Development
True North Therapeutics To Present Clinical Data In Patients With Cold Agglutinin Disease (CAD) For Lead Product Candidate TNT009
May 19, 2016
 · 
1 min read
Business
True North Therapeutics Launches COMPASS Registry To Advance Development Of New Therapeutics For Patients With Cold Agglutinin Disease (And Other Autoimmune Hemolytic Anemias)
March 8, 2016
 · 
4 min read
Drug Development
True North Therapeutics Receives Orphan Drug Designation In The European Union For TNT009 For The Treatment Of Autoimmune Hemolytic Anemia, Including Cold Agglutinin Disease (CAD)
February 25, 2016
 · 
2 min read
Load More